Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Stockholders' Equity

v3.19.1
Condensed Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Preferred Stock [Member]
Class A Common Shares [Member]
Common Shares [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balances at Dec. 31, 2017 $ 59,832 $ 0 $ 0 $ 3 $ 9,558 $ 98,679 $ (48,408)
Balances (in shares) at Dec. 31, 2017   250,000 1,000,000 25,236,255      
Issuance of common shares - Founders Agreement 0 $ 0 $ 0 $ 0 (9,558) 9,558 0
Issuance of common shares - Founders Agreement (in shares)   0 0 834,756      
Stock-based compensation expenses 1,995 $ 0 $ 0 $ 0 0 1,995 0
Stock-based compensation expenses (in shares)   0 0 0      
Exercise of warrants 96 $ 0 $ 0 $ 0 0 96 0
Exercise of warrants (in shares)   0 0 30,543      
Net loss (6,281) $ 0 $ 0 $ 0 0 0 (6,281)
Balances at Mar. 31, 2018 55,642 $ 0 $ 0 $ 3 0 110,328 (54,689)
Balances (in shares) at Mar. 31, 2018   250,000 1,000,000 26,101,554      
Balances at Dec. 31, 2018 36,396 $ 0 $ 0 $ 3 2,085 113,378 (79,070)
Balances (in shares) at Dec. 31, 2018   250,000 1,000,000 26,610,183      
Issuance of common shares - Founders Agreement 0 $ 0 $ 0 $ 0 (2,085) 2,085 0
Issuance of common shares - Founders Agreement (in shares)   0 0 709,314      
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech 375 $ 0 $ 0 $ 0 0 375 0
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech (in shares)   0 0 108,069      
Issuance of warrants - Horizon Note 888 $ 0 $ 0 $ 0 0 888 0
Issuance of warrants - Horizon Note (in shares)   0 0 0      
Stock-based compensation expenses 432 $ 0 $ 0 $ 0 0 432 0
Stock-based compensation expenses (in shares)   0 0 76,000      
Exercise of warrants 0 $ 0 $ 0 $ 0 0 0 0
Exercise of warrants (in shares)   0 0 57,867      
Net loss (9,613) $ 0 $ 0 $ 0 0 0 (9,613)
Balances at Mar. 31, 2019 $ 28,478 $ 0 $ 0 $ 3 $ 0 $ 117,158 $ (88,683)
Balances (in shares) at Mar. 31, 2019   250,000 1,000,000 27,561,433